Uscom Ltd
ASX:UCM
Uscom Ltd
Net Income (Common)
Uscom Ltd
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Uscom Ltd
ASX:UCM
|
Net Income (Common)
-AU$2.6m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
Neurotech International Ltd
ASX:NTI
|
Net Income (Common)
-AU$7.8m
|
CAGR 3-Years
-66%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
ImpediMed Ltd
ASX:IPD
|
Net Income (Common)
-AU$19.4m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-11%
|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Net Income (Common)
-AU$4.7m
|
CAGR 3-Years
8%
|
CAGR 5-Years
-166%
|
CAGR 10-Years
7%
|
Cochlear Ltd
ASX:COH
|
Net Income (Common)
AU$350.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
6%
|
CAGR 10-Years
17%
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Net Income (Common)
-AU$3.9m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-36%
|
CAGR 10-Years
N/A
|
See Also
What is Uscom Ltd's Net Income (Common)?
Net Income (Common)
-2.6m
AUD
Based on the financial report for Jun 30, 2023, Uscom Ltd's Net Income (Common) amounts to -2.6m AUD.
What is Uscom Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-6%
Over the last year, the Net Income (Common) growth was -31%. The average annual Net Income (Common) growth rates for Uscom Ltd have been -25% over the past three years , -6% over the past five years .